Commercialization Phase Sample Clauses

Commercialization Phase. The second phase of the Commercialization ----------------------- Program shall be the Commercialization Phase, during which GE and CCSI will jointly pursue the Commercialization of the Products as developed during the Technology Development Phase. GE and CCSI will conduct their respective efforts in accordance with the Commercialization Plan attached hereto as Exhibit B, as such Commercialization Plan may be modified by the Management Committee under Section 5.1.3 below, Article 7, and any other relevant terms of this Agreement.
Sample 1Sample 2
AutoNDA by SimpleDocs
Commercialization Phase. 12 2.3 Accounting and Internal Controls................................14 2.4 Restrictions....................................................15
Sample 1Sample 2
Commercialization Phase. To the extent that during the Commercialization Phase, Axxxx requires consulting work from Quick-Med for other work due to requests made by Axxxx (and accepted by Quick-Med), then the rate for such work shall be at $2,000 per day per person or fraction thereof at $250 per hour. In addition, the reasonable out-of-pocket expenses for food, lodging, travel, and consumables incurred and for third party expenses (including, without limitation, independent third party consultants and laboratory expenses) incurred by Quick-Med will be separately billed as incurred and paid by Axxxx, subject to Axxxx’x approval of the expenses before they are incurred and the submission to Axxxx of evidence of such out-of-pocket expenses in form and substance reasonably satisfactory to Axxxx. All invoices shall be paid within thirty (30) days of the date thereof.
Sample 1Sample 2
Commercialization Phase. Bayer shall use commercially reasonable efforts during the Commercialization Phase to successfully market each Metabolic Program Drug; provided, however that the decision how to market and whether to continue to market such Metabolic Program Drug shall be up to Bayer in its sole discretion. Article III ----------- Bayer and CuraGen Rights and Obligations ----------------------------------------
Sample 1
Commercialization Phase. If Licensee requests Meiji to supply the Bulk during the period of Product commercialization, Meiji shall do so, subject to ---------- [*] Confidential Treatment Requested the terms and conditions of a separate supply agreement to be negotiated in good faith and executed at the time of such request by Licensee. Such separate agreement shall be consistent with the applicable terms of the Agreement, will contain commercially reasonable terms and conditions as are necessary and appropriate for such a supply agreement, and shall incorporate the following terms among others: (x) Licensee shall pay not less than [*] for the first [*] of the Bulk supplied each year for commercial use, and (y) if Licensee requests more than [*] per year, the separate agreement shall assure the price of the Bulk not less than [*] and compensation to Meiji for its capital investment (if any) necessary to increase its manufacturing capacity to supply Licensee's requirements. Unless such separate agreement is executed by the date of the First Commercial Sale of Product in the United States or Europe, whichever is earlier, Meiji shall have no subsequent obligations to supply the Bulk for commercial use.
Sample 1
Commercialization Phase. If Licensee requests Meiji to supply the Bulk during the period of Product commercialization, Meiji shall do so, subject to the terms and conditions of a separate supply agreement to be negotiated in good faith and executed at the time of such request by Licensee. Such separate agreement shall be consistent with the applicable terms of the Agreement, will contain commercially reasonable terms and conditions as are necessary and appropriate for such a supply agreement, and shall incorporate the following terms among others: (x) Licensee shall pay not less than [ * ] for the first [ * ] of the Bulk supplied each year for commercial use, and (y) if Licensee requests more than [ * ] per year, the separate agreement shall assure the price of the Bulk not less than [ * ] and compensation to Meiji for its capital investment (if any) necessary to increase its manufacturing capacity to supply Licensee's requirements. Unless such separate agreement is executed by the date of the First Commercial Sale of Product in the United States or Europe, whichever is earlier, Meiji shall have no subsequent obligations to supply the Bulk for commercial use.
Sample 1
Commercialization Phase. 30 new jobs created (Scientific, Production, Support) SALES: This product will increase HYDROGENICS' sales by 30% (by $3M) by 2001.
Sample 1
AutoNDA by SimpleDocs
Commercialization Phase. The second phase of the Commercialization ----------------------- Program shall be the Commercialization Phase, during which GE and CCSI will jointly pursue the Commercialization of the Products as developed during the Technology THE SYMBOL "[*]" IS USED TO INDICATE THAT A PORTION OF THE EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. Development Phase. GE and CCSI will conduct their respective efforts in accordance with the Commercialization Plan attached hereto as Exhibit B, as such Commercialization Plan may be modified by the Management Committee under Section 5.1.3 below, Article 7, and any other relevant terms of this Agreement.
Sample 1
Commercialization Phase 
Sample 1Sample 2Sample 3See All (9)

Related to Commercialization Phase

  • Development Phase contractual phase initiated with the approval of ANP for the Development Plan and which is extended during the Production Phase while investments in xxxxx, equipment, and facilities for the Production of Oil and Gas according to the Best Practices of the Oil Industry are required.

  • Development Program A. Development activities to be undertaken (Please break activities into subunits with the date of completion of major milestones)

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Contract Area, including its abandonment.

  • Commercialization Plan On a Product by Product basis, not later than sixty (60) days after the filing of the first application for Regulatory Approval of a Product in the Copromotion Territory, the MSC shall prepare and approve a rolling multiyear (not less than three (3) years) plan for Commercializing such Product in the Copromotion Territory (the "Copromotion Territory Commercialization Plan"), which plan includes a comprehensive market development, marketing, sales, supply and distribution strategy for such Product in the Copromotion Territory. The Copromotion Territory Commercialization Plan shall be updated by the MSC at least once each calendar year such that it addresses no less than the three (3) upcoming years. Not later than thirty (30) days after the filing of the first application for Regulatory Approval of a Product in the Copromotion Territory and thereafter on or before September 30 of each calendar year, the MSC shall prepare an annual commercialization plan and budget (the "Annual Commercialization Plan and Budget"), which plan is based on the then current Copromotion Territory Commercialization Plan and includes a comprehensive market development, marketing, sales, supply and distribution strategy, including an overall budget for anticipated marketing, promotion and sales efforts in the upcoming calendar year (the first such Annual Development Plan and Budget shall cover the remainder of the calendar year in which such Product is anticipated to be approved plus the first full calendar year thereafter). The Annual Commercialization Plan and Budget will specify which Target Markets and distribution channels each Party shall devote its respective Promotion efforts towards, the personnel and other resources to be devoted by each Party to such efforts, the number and positioning of Details to be performed by each Party, as well as market and sales forecasts and related operating expenses, for the Product in each country of the Copromotion Territory, and budgets for projected Pre-Marketing Expenses, Sales and Marketing Expenses and Post-Approval Research and Regulatory Expenses. In preparing and updating the Copromotion Territory Commercialization Plan and each Annual Commercialization Plan and Budget, the MSC will take into consideration factors such as market conditions, regulatory issues and competition.

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection xxxxx; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

  • Research Program 2.1 University will use reasonable efforts to conduct the Research Program described in Attachment A which is hereby incorporated in full by reference (“Research Program”), and will furnish the facilities necessary to carry out said Research Program. The Research Program will be under the direction of _____________________ (“Principal Investigator”), or his or her successor as mutually agreed to by the Parties and will be con­ducted by the Principal Investigator at the University.

  • Research Collaboration Upon FibroGen’s request, the Parties will discuss conducting a research program funded by AstraZeneca and directed toward franchise enhancement and lifecycle management for HIF Compounds or other topics that the Parties determine relevant to the Products and the Field. Upon agreement on the terms of such research program, the Parties will enter into a separate agreement or amend this Agreement accordingly.

  • Development Period The Contractor may commence pre-construction activities like utility shifting, boundary wall construction or any other activity assigned to the Contractor by the Authority to enable construction of the Project Highway immediately after signing of the Agreement, to the extent that such work is ready for execution. The Parties agree that these works may be taken up and completed to the extent feasible by the Contractor, before declaration of the Appointed Date, but no claim against the Authority for delay shall survive during this period and that the undertaking of these works by the Contractor shall not count towards the Scheduled Construction Period of the project which starts counting only from the Appointed Date. No construction activity of the Project Highway shall be undertaken during the development period.

Time is Money Join Law Insider Premium to draft better contracts faster.